Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue*

Arachidonylethanolamide (AEA) isolated from porcine brain binds to cannabinoid receptors, mimics cannabinoid pharmacologic effects, and has been proposed as an endogenous cannabinoid receptor ligand. Demonstration of co-distribution of AEA and cannabinoid receptors in various brain regions could provide supportive evidence for this role. We have performed isotope dilution mass spectrometric measurements of AEA and have demonstrated AEA production by rat tissue homogenates in vitro from exogenous arachidonate and ethanolamine. No detectable endogenous AEA (<3.5 pmol/g of tissue) was observed in fresh rat brain, whether or not inhibitors of AEA hydrolysis were present during tissue processing. AEA (>1 nmol/g) was produced during saponification of brain phospholipid extracts. This appears not to reflect hydrolysis of N-arachidonylethanolamine phospholipid precursors of AEA, because Streptomyces chromfucsis phospholipase D, which is active against NAPE, failed to generate AEA from brain phospholipids despite substantial conversion of phospholipids to phosphatidic acid. Such experiments suggested that the abundance of N-arachidonylethanolamine phospholipid in fresh rat brain may be less than 1 in 106 phospholipid molecules. AEA generated during saponification of tissue phospholipids appears to arise from base-catalyzed aminolysis of arachidonate-containing glycerolipids, because AEA was produced from synthetic (1-stearoyl, 2-arachidonoyl)-phosphatidylethanolamine under saponification conditions, and the amount produced increased 300-fold when free ethanolamine was included in the hydrolysis solution. Although AEA was not detectable (<0.17 pmol/mg of protein) in fresh rat brain, AEA accumulated post mortem to levels of 126 pmol/mg of brain protein. These findings do not exclude the possibility that AEA is rapidly synthesized and degraded locally in vivo, but they indicate that the AEA content of fresh rat brain and of NAPE precursors from which AEA might be derived are exceedingly low and that AEA can be produced artifactually from biological materials.

[1]  N. Ueda,et al.  Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*) , 1995, The Journal of Biological Chemistry.

[2]  D. Piomelli,et al.  Anandamide Amidohydrolase Activity in Rat Brain Microsomes , 1995, The Journal of Biological Chemistry.

[3]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[4]  L. Iversen Endogenous cannabinoids , 1994, Nature.

[5]  J. Axelrod,et al.  Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Gross,et al.  The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor. , 1994, The Journal of biological chemistry.

[7]  A. Howlett,et al.  Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  S. Childers,et al.  Effects of anandamide on cannabinoid receptors in rat brain membranes. , 1994, Biochemical pharmacology.

[9]  W. Devane New dawn of cannabinoid pharmacology. , 1994, Trends in pharmacological sciences.

[10]  R. Gross,et al.  Mass spectrometric characterization of arachidonate-containing plasmalogens in human pancreatic islets and in rat islet beta-cells and subcellular membranes. , 1993, Biochemistry.

[11]  K. Mackie,et al.  Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. , 1993, Molecular pharmacology.

[12]  D. Deutsch,et al.  Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. , 1993, Biochemical pharmacology.

[13]  K. Mackie,et al.  Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Mechoulam,et al.  Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase , 1993, Journal of neurochemistry.

[15]  S. Heald,et al.  Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  R. Gross,et al.  Mass spectrometric identification and quantitation of arachidonate-containing phospholipids in pancreatic islets: prominence of plasmenylethanolamine molecular species. , 1993, Biochemistry.

[17]  R. Mechoulam,et al.  Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. , 1993, European journal of pharmacology.

[18]  T. Bonner,et al.  Localization of cannabinoid receptor mRNA in rat brain , 1993, The Journal of comparative neurology.

[19]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[20]  L. Matsuda,et al.  Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. , 1992, Molecular pharmacology.

[21]  R. Mechoulam,et al.  A random walk through a cannabis field , 1991, Pharmacology Biochemistry and Behavior.

[22]  G Vassart,et al.  Molecular cloning of a human cannabinoid receptor which is also expressed in testis. , 1991, The Biochemical journal.

[23]  M. Reichman,et al.  Delta 9-tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices. , 1991, Molecular pharmacology.

[24]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[26]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.

[28]  H. Schmid,et al.  Hydrolysis of N-acylated glycerophospholipids by phospholipases A2 and D: a method of identification and analysis. , 1986, Chemistry and physics of lipids.

[29]  S. G. Laychock,et al.  Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol. , 1986, Biochemical pharmacology.

[30]  L E Hollister,et al.  Health aspects of cannabis. , 1986, Pharmacological reviews.

[31]  H. Schmid,et al.  Occurrence of N-acylethanolamine phospholipids in fish brain and spinal cord. , 1985, Biochimica et biophysica acta.

[32]  P. Comens,et al.  Arachidonic acid metabolism in isolated pancreatic islets. IV. Negative ion-mass spectrometric quantitation of monooxygenase product synthesis by liver and islets. , 1985, Biochimica et biophysica acta.

[33]  M. Mcdaniel,et al.  Arachidonic acid metabolism in isolated pancreatic islets. III. Effects of exogenous lipoxygenase products and inhibitors on insulin secretion. , 1985, Biochimica et biophysica acta.

[34]  M. Mcdaniel,et al.  Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis. , 1984, Biochimica et biophysica acta.

[35]  E. Corey,et al.  RATIONALLY DESIGNED, POTENT COMPETITIVE INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS , 1984 .

[36]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[37]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[38]  H. Schmid,et al.  N-acylated glycerophospholipids and their derivatives. , 1990, Progress in lipid research.

[39]  S. Burstein,et al.  Prostaglandins and cannabis--VI. Release of arachidonic acid from HeLa cells by delta1-tetrahydrocannabinol and other cannabinoids. , 1978, Biochemical pharmacology.